{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:02:56Z","timestamp":1790488976939,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["W-31-109-Eng-38"],"award-info":[{"award-number":["W-31-109-Eng-38"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016820","name":"Vaccine Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.immuni.2025.01.010","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T11:02:19Z","timestamp":1738666939000},"page":"295-308.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350"],"prefix":"10.1016","volume":"58","author":[{"given":"M. Gordon","family":"Joyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Tsybovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep R.","family":"Narpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Nabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-1532","authenticated-orcid":false,"given":"Masaru","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2025.01.010_bib1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2025.01.010_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2025.01.010_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7314\/APJCP.2015.16.1.265","article-title":"Burden of virus-associated liver cancer in the Arab world, 1990\u20132010","volume":"16","author":"Khan","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.immuni.2025.01.010_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.immuni.2025.01.010_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2025.01.010_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.01.010_bib7","first-page":"160","article-title":"Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications","volume":"19","author":"Bjornevik","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.immuni.2025.01.010_bib8","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-Barr virus entry","volume":"81","author":"Hutt-Fletcher","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2025.01.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2025.01.010_bib11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/jvi.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib12","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1016\/S0021-9258(19)38344-9","article-title":"Structural requirements for C3d,g\/Epstein-Barr virus receptor (CR2\/CD21) ligand binding, internalization, and viral infection","volume":"265","author":"Carel","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2025.01.010_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nsmb1161","article-title":"Structure of the Epstein-Barr virus major envelope glycoprotein","volume":"13","author":"Szakonyi","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nsmb0507-354a","article-title":"Building meaningful models of glycoproteins","volume":"14","author":"Crispin","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib15","doi-asserted-by":"crossref","first-page":"36614","DOI":"10.1074\/jbc.M706324200","article-title":"Isolating the Epstein-Barr virus gp350\/220 binding site on complement receptor type 2 (CR2\/CD21)","volume":"282","author":"Young","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2025.01.010_bib16","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1128\/JVI.01673-08","article-title":"Molecular basis of the interaction between complement receptor type 2 (CR2\/CD21) and Epstein-Barr virus glycoprotein gp350","volume":"82","author":"Young","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1132740","article-title":"The efficacy and safety of nirsevimab for the prevention of RSV infection among infants: A systematic review and meta-analysis","volume":"11","author":"Turalde-Mapili","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.immuni.2025.01.010_bib18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants","volume":"388","author":"Muller","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2025.01.010_bib19","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4161\/hv.29635","article-title":"Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants","volume":"10","author":"Forbes","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.immuni.2025.01.010_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285672","article-title":"A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B","volume":"18","author":"Okamoto","year":"2023","journal-title":"PLOS One"},{"key":"10.1016\/j.immuni.2025.01.010_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03294-z","article-title":"Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH","volume":"5","author":"Parsons","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168728","article-title":"Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection","volume":"22","author":"Struble","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2025.01.010_bib23","article-title":"Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas","volume":"7","author":"Tabata","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.immuni.2025.01.010_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00430-019-00613-w","article-title":"Survey of cellular immune responses to human cytomegalovirus infection in the microenvironment of the uterine-placental interface","volume":"208","author":"Tabata","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.immuni.2025.01.010_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.coviro.2021.12.002","article-title":"Recent progress in development of monoclonal antibodies against human cytomegalovirus","volume":"52","author":"Ye","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7326\/M21-3669","article-title":"Update on and Future Directions for Use of Anti-SARS-CoV-2 Antibodies: National Institutes of Health Summit on Treatment and Prevention of COVID-19","volume":"175","author":"Boggiano","year":"2022","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.immuni.2025.01.010_bib27","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.77.5.2979","article-title":"Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.01.010_bib28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<624::AID-IJC19>3.0.CO;2-B","article-title":"Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice","volume":"71","author":"Abedi","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.immuni.2025.01.010_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/505912","article-title":"A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in\u00a0vitro and in\u00a0vivo","volume":"194","author":"Haque","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2025.01.010_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2021.06.006","article-title":"Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV","volume":"561","author":"Kim","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2025.01.010_bib32","article-title":"Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model","volume":"2","author":"M\u00fche","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.immuni.2025.01.010_bib30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells","volume":"50","author":"Bu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.01.010_bib33","doi-asserted-by":"crossref","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","article-title":"The need and challenges for development of an Epstein-Barr virus vaccine","volume":"31","author":"Cohen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2025.01.010_bib34","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.01.010_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf3685","article-title":"A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice","volume":"14","author":"Wei","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2025.01.010_bib36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1201954","article-title":"A crystal structure of the complex between human complement receptor 2 and its ligand C3d","volume":"332","author":"van den Elsen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.immuni.2025.01.010_bib37","doi-asserted-by":"crossref","first-page":"10641","DOI":"10.1073\/pnas.162360499","article-title":"The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding","volume":"99","author":"Prota","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.01.010_bib38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.167.3.1490","article-title":"Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350\/220","volume":"167","author":"Sarrias","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2025.01.010_bib39","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkn201","article-title":"NCBI BLAST: a better web interface","volume":"36","author":"Johnson","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2025.01.010_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00430-018-0565-y","article-title":"Macaca arctoides gammaherpesvirus 1 (strain herpesvirus Macaca arctoides): virus sequence, phylogeny and characterisation of virus-transformed macaque and rabbit cell lines","volume":"208","author":"Krumbholz","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.immuni.2025.01.010_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2015.10.025","article-title":"The genomic sequence of lymphocryptovirus from cynomolgus macaque","volume":"488","author":"Kamperschroer","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2025.01.010_bib42","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/jvi.70.11.7819-7826.1996","article-title":"Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1","volume":"70","author":"Franken","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib43","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1128\/JVI.76.23.12055-12068.2002","article-title":"Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world\u00a0primate: a defining point in the evolution of oncogenic lymphocryptoviruses","volume":"76","author":"Rivailler","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-021-00935-6","article-title":"Chromosomal-scale de novo genome assemblies of Cynomolgus Macaque and Common Marmoset","volume":"8","author":"Jayakumar","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.immuni.2025.01.010_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6150-9-20","article-title":"A new rhesus macaque assembly and annotation for next-generation sequencing analyses","volume":"9","author":"Zimin","year":"2014","journal-title":"Biol. Direct"},{"key":"10.1016\/j.immuni.2025.01.010_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41586-021-03535-x","article-title":"Evolutionary and biomedical insights from a marmoset diploid genome assembly","volume":"594","author":"Yang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.01.010_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.01.010_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006913","article-title":"Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques","volume":"14","author":"Klasse","year":"2018","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.immuni.2025.01.010_bib49","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.celrep.2016.07.074","article-title":"Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies","volume":"16","author":"McCoy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2025.01.010_bib50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ni.3533","article-title":"Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination","volume":"17","author":"Ellebedy","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.01.010_bib51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.immuni.2025.01.010_bib52","article-title":"Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability","volume":"12","author":"Mason","year":"2016","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.immuni.2025.01.010_bib53","first-page":"241","article-title":"Primary Immunodeficiencies Associated with EBV Disease","volume":"390","author":"Cohen","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.immuni.2025.01.010_bib54","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2025.01.010_bib57","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.immuni.2022.10.003","article-title":"Epstein-Barr virus gH\/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition","volume":"55","author":"Chen","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.01.010_bib80","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2025.01.010_bib81","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.01.010_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/356347a0","article-title":"Epstein-Barr virus infection and replication in a human epithelial cell system","volume":"356","author":"Li","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.01.010_bib56","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V\u2013D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2025.01.010_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.immuni.2025.01.010_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","article-title":"Integration, scaling, space-group assignment and post-refinement","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1107\/S0021889808006985","article-title":"CHAINSAW: a program for mutating pdb files used as templates in molecular replacement","volume":"41","author":"Stein","year":"2008","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib65","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1107\/S0907444904010145","article-title":"The importance of alignment accuracy for molecular replacement","volume":"60","author":"Schwarzenbacher","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1107\/S2059798323003595","article-title":"The CCP4 suite: integrative software for macromolecular crystallography","volume":"79","author":"Agirre","year":"2023","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.immuni.2025.01.010_bib68","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib69","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.immuni.2025.01.010_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01456","article-title":"Collaboration gets the most out of software","volume":"2","author":"Morin","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2025.01.010_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-1036-7_1","article-title":"The Clustal Omega Multiple Alignment Package","volume":"2231","author":"Sievers","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib73","doi-asserted-by":"crossref","first-page":"W597","DOI":"10.1093\/nar\/gkt376","article-title":"Analysis Tool Web Services from the EMBL-EBI","volume":"41","author":"McWilliam","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2025.01.010_bib74","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.immuni.2025.01.010_bib75","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCo-distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2025.01.010_bib76","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2025.01.010_bib77","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2025.01.010_bib79","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","article-title":"RELION: implementation of a Bayesian approach to cryo-EM structure determination","volume":"180","author":"Scheres","year":"2012","journal-title":"J.\u00a0Struct. Biol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:25:42Z","timestamp":1762363542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761325000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1074761325000354"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2025.01.010","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2025.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}